FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| Pine Pharmaceuticals LLC | 69194-138 | 69194-138-01 | 138 BUPIVACAINE HCL 0.375%, LIDOCAINE HCl 2% SYRINGE | bupivacaine HCL, lidocaine HCl | 3.75 mg/1 mL; 20 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| Pine Pharmaceuticals LLC | 69194-138 | 69194-138-01 | 138 BUPIVACAINE HCL 0.375%, LIDOCAINE HCl 2% SYRINGE | bupivacaine HCL, lidocaine HCl | 3.75 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2025-1 | valid | 2026-10-06 | ||
| Pine Pharmaceuticals LLC | 69194-138 | 69194-138-01 | 138 BUPIVACAINE HCL 0.375%, LIDOCAINE HCl 2% SYRINGE | bupivacaine HCL, lidocaine HCl | 3.75 mg/1 mL; 20 mg/1 mL | 2025-1 | valid | 2026-09-18 |